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Abstract
Introduction Pancreatic ductal adenocarcinoma has a high mortality rate with limited treatment options. One option is
pancreaticoduodenectomy, although complete resection may require venous resection. Pancreaticoduodenectomy with
venous resection and reconstruction is becoming a more common practice with many choices for venous reconstruction. We
describe the technique of using the left renal vein as a conduit for venous reconstruction during pancreaticoduodenectomy.
Methods The technique for use of the left renal vein as an interposition graft for venous reconstruction during
pancreaticoduodenectomy is described as well as outcomes for nine patients that have undergone the procedure.
Results Nine patients, seven men, with a mean age of 57 years, have undergone the operation. There were eight
interposition grafts and one patch graft. Mean operating time was 7.8 hours, and mean tumor size was 3.4 cm. Eight patients
had node-positive disease, and six had involvement of the vein. Mean hospital stay was 14 days and perioperative morbidity
included a superficial wound infection, delayed gastric emptying, ascites, and gastrointestinal bleeding in one patient each.
Creatinine ranged from 0.8–1.1 mg/dl preoperatively and from 0.7–1.3 mg/dl at discharge. Mean follow-up was 6.8 months
with normal creatinine values noted through the follow-up period. Two patients had died during follow-up from recurrent
disease at 8.3 and 18.2 months after the operation.
Conclusions The left renal vein provides an additional choice for an autologous graft during pancreaticoduodenectomy with
venous resection. The ease of harvesting the graft and maintenance of renal function distinguish its use.
Keywords Pancreaticcancer.Pancreaticoduodenectomy.
Venousresection.Portalvein.Superiormesentericvein.
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Introduction
Pancreatic ductal adenocarcinoma has a high mortality
rate
1, which approaches the incidence, and treatment
options remain limited. For those patients diagnosed with
pancreatic ductal adenocarcinoma, resection continues to
offer the only chance for cure. Historically, involvement of
local vasculature was considered a contraindication to
pancreaticoduodenectomy (PD), with early experience
associated with prohibitively high morbidity and mortality
rates.
2 As surgeon experience has grown, morbidity and
mortality rates have decreased, and at high-volume pancre-
atic surgery centers, invasion of local mesenteric venous
structures is no longer a contraindication to resection.
Venous resection occurs in up to 25% of patients
undergoing PD at several centers.
3,4 Several techniques
are described for reconstruction of the venous system after
PD when necessary: primary lateral venorrhaphy, primary
end-to-end anastomosis, and interposition grafting.
5,6 Both
synthetic grafts and autologous vein grafts have been used,
with several donor sites available.
3,7
The goal of this report is to describe the use of the
left renal vein as a conduit for venous reconstruction
after PD with venous resection. Historically, the left renal
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or inferior vena cava during resection of hepatic hilar
carcinomas,
8–11 and its use offers distinct advantages for
venous reconstruction during PD. Importantly, previous
studies have demonstrated the safety of left renal vein
ligation, specifically in relation to renal function.
12 We
describe the technique of mesenteric venous reconstruction
after PD with venous resection using a left renal vein graft
and report on a group of patients that have undergone this
repair.
Patient Selection and Technique
Contrast-enhanced computed tomography (CT) is used to
evaluate a pancreatic head mass and its relation to vascular
structures. CT accurately diagnoses mesenteric vein involve-
ment, aiding in operative planning. The CT is also used to
assess the length and caliber of the left renal vein, the status
of the kidneys bilaterally, and the presence of the left
gonadal and adrenal veins, which serve as collateral venous
drainage. Additional imaging of the pancreas with endo-
scopic ultrasound (EUS) is frequently used to further
evaluate the location and extent of any venous involvement.
After initiation of the operation, a Kocher maneuver
allows assessment of tumor location and its relationship
to the superior mesenteric artery (SMA), further assessing
resectability. The lesser sac is entered by mobilizing the
greater omentum off of the transverse colon through an
avascular plane. The middle colic vein is followed
centrally to identify the superior mesenteric vein (SMV)
and the gastrocolic venous trunk. The gastrocolic venous
trunk is routinely divided. (Fig. 1a) If venous resection is
anticipated, to increase mobility, the middle colic vein and
several other tributaries are ligated and divided. (Fig. 1b)
The superior border of the pancreas is approached by
incising the gastrohepatic ligament. The right gastric and
gastroduodenal arteries are routinely ligated and divided.
Retraction of the common hepatic artery cephalad allows
dissection of the portal vein (PV), thereby, allowing comple-
tion of the plane between the pancreas and the PV-SMV.
The gallbladder is dissected from the liver, and the
hepatic duct is encircled near the cystic duct junction. If a
pylorus-preserving PD is planned, the superior and inferior
aspects of the duodenum are skeletonized, individually
ligating the right gastroepiploic vessels. The ligament of
Treitz is mobilized, and the proximal jejunum is divided.
Sequential ligation and division of the bowel mesentery
Figure 1 a Division of gastro-
colic venous trunk and middle
colic vein. b Mobilization of
superior mesenteric vein in prep-
aration of venous reconstruction.
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jejunum are passed beneath the superior mesenteric vessels
into the right upper quadrant.
Mobilization is now complete and transection begins at
the duodenum approximately 3 cm distal to the pylorus.
The bile duct is transected, and the margin is evaluated for
malignancy. Stay sutures are placed on the superior and
inferior borders of the pancreas to aid in retraction and
hemostasis. The neck of the pancreas is transected over a
clamp to protect the portal vein. (Fig. 2a) Reflection
laterally allows visualization and ligation of venous
tributaries. (Fig. 2b)
Often, venous invasion is not discovered until this
juncture, and although some resections can be limited to
tangential excision and primary lateral venorrhaphy, there
are oncologic and vascular considerations that make other
options, including segmental resection with primary end-to-
end anastomosis or interposition grafting with autologous
or synthetic material, advantageous. Early in our experi-
ence, we completed venous resection before division of the
arterial branches and soft tissue along the right lateral
aspect of the superior mesenteric artery (SMA) (Fig. 3a).
More recently, we have altered our technique by performing
the dissection of the retroperitoneal margin before venous
resection. The advantages of this are to avoid the need for
venous anastomosis before removal of the specimen, mini-
mize venous occlusion time, and allow preservation of the
splenic vein. This is accomplished by performance of a
Figure 2 a The neck of the
pancreas is transected over a
clamp, thereby, protecting the
portal vein from injury. b Venous
tributaries to the portal vein are
individually ligated while mobi-
lizing the head and uncinate
process of the pancreas.
Figure 3 Dissection of the su-
perior mesenteric artery proxi-
mal and distal to the area of
venous invasion will limit total
venous occlusion time after re-
section is performed. This can
be approached anteriorly (a)o r
posteriorly (b) as necessary. In-
flow occlusion of the SMA
during posterior dissection is
used selectively if maintenance
of hemostasis is problematic.
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mesenteric artery both at its origin and caudad to the uncinate
process.TheKochermaneuverorientsthesuperiormesenteric
artery posterior to the PV-SMV and allows access for
completion of the retroperitoneal dissection (Fig. 3b). Arterial
branches coursing into the uncinate are sequentially
clamped, divided, and ligated, thereby, completely freeing
the pancreas from the SMA. The pancreatic head is then
rotated back to its normal anatomic orientation, and it is at
this juncture that a decision is made for primary end-to-end
venous reconstruction or renal vein interposition grafting.
Mobilizationofthe portalveinsuperiortothe pancreasand
the peritoneum along the root of the small bowel mesentery
may provide length for the SMV or PV segment. This is
accomplished by ligating and dividing small branches to the
SMV, PV, and splenic vein (SV). Although primary end-to-
end anastomosis is preferred, if interposition grafting is
necessary, autologous vein and specifically the left renal vein
is utilized for two reasons. First, the vein may be exposed
within the same operative field, thereby, eliminating a second
operative field and dissection. Second, the caliber and wall
thickness of the vein is similar to the portal vein in most
instances, providing good handling and suturing properties.
Harvest of the left renal vein is undertaken after the
retroperitoneal dissection when the specimen remains at-
tached to the portal vein segment only (before venous
resection). This allows the best assessment of the need for
interposition grafting and minimizes the amount of clamp
time by harvesting the graft before SMA and venous
occlusion.
The left renal vein is optimally exposed by extending the
Kocher maneuver to the left and elevating the head of
the pancreas. (Fig. 4a) The vein is divided at the junction of
the left gonadal and left adrenal veins, always preserving
these vessels as collateral venous outflow for the left kidney.
The vein is divided again flush with the inferior vena cava.
(Fig. 4b) This typically provides a 3- to 4-cm venous
segment. For venous division, we prefer a linear stapling
device. The vein segment is placed in heparinized saline
and then can be used as an interposition graft. (Fig. 4c)
Vascular control includes the SMA with placement of a
Rummel tourniquet (in addition to venous occlusion
proximal and distal) and is obtained immediately before
resection. This allows inflow occlusion during the resection
and reconstruction, decreasing the amount of intestinal
engorgement, thereby, facilitating an easier pancreaticojeju-
nostomy. The patient is not systemically heparinized.
Venous resection is done sharply to obtain a margin.
(Fig. 5) If the specimen has not been entirely freed from
the SMA, the remaining branches are now ligated. Com-
munication between the surgical and pathological teams is
crucial to fully evaluate the specimen. Of specific impor-
tance is the venous segment for margin status and invasion
and the retroperitoneal (uncinate) margin. (Fig. 6) Frozen
section analysis allows additional margin to be obtained if
necessary before reconstruction. After completion of both
anastomoses, intraoperative ultrasound is routinely utilized
to evaluate the reconstruction for patency. After satisfactory
venous reconstruction, the remainder of the gastrointestinal
reconstruction is completed. (Fig. 7)
Figure 4 a The Kocher maneu-
ver is extended to the left and
elevation of the pancreatic head
allows exposure of the entire left
renal vein and the left adrenal
and gonadal veins. b The vein is
transected with a linear stapling
device distal to the insertion of
the left adrenal and gonadal
veins and again flush with the
inferior vena cava. c The left
renal vein is used as an interpo-
sition graft to restore continuity
to the mesenteric venous system.
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Nine patients have undergone reconstruction of the SMV-
PV during PD with an autologous left renal vein graft.
There were seven men and two women with a mean age of
57 years (range, 31–77). Preoperative abdominal CT had
suggested mesenteric vein involvement in seven of the nine
patients. EUS was completed in three patients. In one
patient, EUS suggested there was no vein involvement,
while in the remaining two patients, EUS did suggest
involvement. Preoperative serum creatinine levels ranged
from 0.8 to 1.1 mg/dl in these patients (normal values 0.9–
1.4 mg/dl ). Mean follow-up was 6.8 months.
The procedure consisted of three standard PD and six
pylorus-preserving PD. Venous reconstruction consisted of
eight interposition grafts and one patch graft. The patch
graft was located on the lateral edge of the SMV and PV.
Five of the interposition grafts were placed in the SMV,
inferior to the confluence. One interposition graft was
placed between the SMVand PV with reimplantation of the
splenic vein; an additional was placed between the SMV
and PV without reimplantation of the splenic vein, and the
final graft was in the portal vein. The mean operating time
was 7.8 hours (range, 6.5–9.5). The mean tumor size was
3.4 cm (range, 2.2–5). The mean estimated blood loss was
1,300 ml (range, 350–2,500). Eight patients were found to
have node-positive disease with six of these patients noted
to have histological involvement of the venous segment,
Figure 7 In the example shown, reconstruction of the PV-SMV
confluence with an interposition graft utilizing left renal vein was
performed initially, followed by reimplantation of the splenic vein into
the graft (end-to-side) Gastrointestinal reconstruction is performed in a
standard fashion after completion of venous reconstruction.
Figure 6 The specimen is carefully marked for all margins,
including the venous segment margin. The portal vein groove and
the retroperitoneal margin should be inked, and the venous
segment should be evaluated histologically for malignant invasion
(posterior view).
Figure 5 Vascular clamps are used to control the superior mesenteric
vein, splenic vein, and portal vein before sharp dissection and
resection of the involved venous segment. Inflow occlusion of the
superior mesenteric artery during reconstruction reduces bowel
engorgement.
Table 1 A Comparison of Creatinine Levels
Serum Creatinine Concentrations (mg/dL)
Patient Preoperative Peak Time of Discharge
1 1.1 1.1 1.1
2 1.1 1.4 1.1
3 1 1.5 1
4 0.9 1.3 1.1
5 1 1.3 1
6 0.9 1.3 1.3
7 0.8 0.9 0.9
8 0.8 1.1 0.9
9 0.8 0.8 0.7
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lymph nodes and no evidence of malignant invasion of the
vein. In two patients, the uncinate margin was microscop-
ically positive.
One patient was monitored overnight in the intensive
care unit. There were no operative mortalities, and
reoperation was not required in any of the patients. The
mean length of hospitalization was 14 days (range, 9–29).
Immediate perioperative morbidity included a superficial
wound infection in one patient, delayed gastric emptying in
one patient, and postoperative gastrointestinal bleeding in
one patient. None of the patients experienced a pancreatic
leak. No hematuria was noted. One patient was diagnosed
with ascites and stenosis of the left renal vein interposition
graft anastomosis 1 month after the operation. This patient
had a congenitally cystic (nonfunctioning) left kidney. The
left renal vein was reduced in caliber, but felt to be adequate
for grafting at the time of the original operation. The patient
underwent stenting of the graft by interventional radiology
with resolution of her symptoms. Eight patients underwent
adjuvant treatment, which included radiation therapy in six
patients. None of the six patients receiving radiation therapy
experienced a decrement in renal function after radiation
therapy. Two patients had died 8.3 and 18.2 months after the
operation of recurrent disease. Median survival has not been
reached.
After discharge, all patients were evaluated with contrast-
enhanced CT. All grafts were patent, and both kidneys were
perfused well. Renal function was monitored by following
serum creatinine levels. After the operation, creatinine levels
transiently increased, but normalized by discharge. (Table 1)
Creatinine values were available for a mean of 6.8 months
postoperatively, with all levels within the normal range. One
patient was anticoagulated with clopidogrel, while subse-
quent patients were treated with aspirin. Our current
protocol is to treat all patients with daily aspirin if no clot
is noted on the postoperative imaging, and heparin
transitioned to coumadin if clot is noted.
Discussion
Venous resection and reconstruction is not uncommon
during PD at high volume centers.
3,4 Involvement of the
vein by malignancy is not always suggested preoperatively
by imaging and is often discovered at a time during the
operation after commitment has already been made to
resection. This fact necessitates that the surgeon has a plan
for completing the resection and reconstruction of the venous
system.
13 Whereas many such cases can be completed with
segmental resection and primary end-to-end anastomosis, a
number will require either patch repair or interposition
grafting. Other groups routinely use the internal jugular
vein
3 or superficial femoral vein
14 as a conduit. While
these groups have demonstrated good results with these
conduits, the use of the left renal vein for autologous
grafting offers some significant advantages and avoids the
handling difficulties that can be encountered with the
internal jugular vein and the risk of lymphedema or venous
thrombosis that can be encountered with use of the
superficial femoral vein.
The left renal vein provides a graft with good length,
good caliber, and is easily accessible. The left renal vein
typically provides a graft of 3–4 cm in length when
harvested from the junction of the left gonadal and left
adrenal vein proximally and the inferior vena cava distally,
although some reports have indicated lengths up to 6 cm.
9
The caliber of the graft allows for excellent flow, as
demonstrated by CT and Doppler ultrasound. The ease of
harvesting the graft also is an important consideration.
Exposure of the left renal vein can be accomplished
through a standard PD incision, without requiring any
further prepping, an additional incision, or the need for an
additional operating team. Furthermore, use of the left renal
vein leaves the patient with all possible routes of central
venous access.
Importantly, the operation is tolerated well from a renal
standpoint. Previous work demonstrated that good collater-
al flow and functional capacity of the left kidney is
preserved despite ligation of the left renal vein. McCullough
and colleagues reported that after a right nephrectomy
and ligation of the left renal vein for malignancy, only
one of three patients experienced transient renal insuffi-
ciency.
12 In our series, serum creatinine levels transiently
increased after operation, but all normalized before dis-
charge. Creatinine levels remained normal throughout
follow-up.
Conclusions
Resection offers the only chance at cure for patients with
pancreatic cancer, and potentially curative resection may
require venous resection. When reconstruction of the venous
system necessitates the use of interposition grafting, autolo-
gous vein interposition grafts are preferred. The left renal
vein provides an additional choice for an autologous graft,
and its use is distinguished by ease of harvest and
maintenance of renal function. The use of the left renal vein
for interposition grafting and patch repair should be consid-
ered by surgeons experienced in SMV-PV reconstruction
during PD.
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